Calendar iBio, Inc.

Equities

IBIO

US4510337086

Market Closed - Nyse 01:00:00 2024-07-03 pm EDT 5-day change 1st Jan Change
1.97 USD +1.03% Intraday chart for iBio, Inc. -6.19% +43.80%

Chart calendar iBio, Inc.

a2b227f3018e3b1386993290f7533255.PxWCZllTc3GM4DpVtz_f0gGnawDqvvKbsUAkXCVPpt4.cXDFAAY5Q0W6tQwX40W16zfuNEq407Xi6HVTaRMe6_NtX_cjNh85C8DXVQ~704ae852e48a74faa3e86c0ee03bdb56

Upcoming events on iBio, Inc.

2024-09-23 Q4 2024 Earnings Release (Projected)
2025-05-18 Q3 2025 Earnings Release (Projected)
2025-09-29 Q4 2025 Earnings Release (Projected)
2026-05-17 Q3 2026 Earnings Release (Projected)

Past events on iBio, Inc.

2024-05-13 04:05 pm Q3 2024 Earnings Release
2024-03-27 08:30 am Business Update Call
2024-01-16 08:15 pm PepTalk Conference
2023-11-28 Reverse Split: 1 of 20
2023-11-27 04:00 pm Annual General Meeting
2023-10-12 06:20 am Biologics Festival - Enhancing Bispecific T Cell Engager Discovery
2023-10-10 08:20 am Biologics Festival - Pitfalls to Avoid When Building an AI-Driven Platform Company
2023-09-27 04:19 pm Q4 2023 Earnings Release
2023-05-16 12:00 pm JMP Securities Life Sciences Conference - Fireside Chat
2022-12-07 01:20 pm JMP Securities Hematology and Oncology Summit
2022-12-03 Antibody Engineering & Therapeutics Conference - Epitope-Targeted
2022-12-03 Antibody Engineering & Therapeutics Conference - Fully Human & Developable Antibody
2022-10-09 Reverse Split: 1 of 25
2022-09-27 04:30 pm FY 2022 Earnings Call
2022-09-27 04:10 pm FY 2022 Earnings Release
2022-06-30 09:30 am Extraordinary Shareholders Meeting
2022-05-23 H.C. Wainwright Global Life Sciences Investment Conference
2022-05-12 04:30 pm Q3 2022 Earnings Call
2022-05-12 04:05 pm Q3 2022 Earnings Release
2022-05-01 Protein & Antibody Engineering Summit Boston Conference & Expo

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
2,02


1,64
0,60
173%
2,37
2,60
-8.81%
2,38
2,50
-4.68%
0,39
0,50
-21.8%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-14,0
-15,9
11.93%
-31,1
-29,5
-5.46%
-49,7
-43,2
-15.02%
0,00
0,00
-

-17,0

Earnings before Tax (EBT)
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

Net income
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EPS
USD
Released
Forecast
Spread
-470


0,00
0,00
-
0,00
0,00
-
-116
-115
-0.52%
0,00
0,00
-

0,00

Announcement Date26/08/1913/10/2027/09/2111/10/2227/09/23-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q2 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
1,94
0,20
871.5%
0,06
0,20
-69.5%
0,00
0,60
-
0,13
0,60
-78.33%
0,21
0,20
2.5%
0,00
0,20
-
0,00



0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
-12,2
-11,4
-6.86%
-16,9
-12,2
-38.49%
-7,64
-17,9
57.34%
-10,6
-6,80
-55.49%
























EPS
USD
Released
Forecast
Spread
-30,0
-30,0
0%
-113
-40,0
-181.5%
-41,0
-35,0
-17.14%









-4,42

















Announcement Date12/05/2211/10/2214/11/2214/02/2315/05/2327/09/2315/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise